Replies to post #58786 on NorthWest Biotherapeutics Inc (NWBO)

[chinatown1980]

Good question

[VMLG17]

Pathetic arguement.

[TheFollower]

Speaking of dilution:

I believe in 3 weeks we will be coming upon a portion of the last deal made to the existing investors.
Correct me if I'm wrong on this, but if I got it right, I am tossed between 2 scenarios:
- hoping the price goes above the $3.00 mark after the 60 day period (with no dilution)
- hoping for some news and having the price rise above $3.00 (with dilution)
That would mean 5,880,000 shares x $3.00 = $17,640,000
...at the current burn rate that would cover a quarter an a half.

I'm leaning toward waiting until May.
Would that not be better for us, unless the money was desperately needed?

http://www.nwbio.com/nw-bio-announces-registered-direct-offering-of-up-to-27-6-million-with-existing-institutional-investors/
FEB 2016
NW Bio Announces Registered Direct Offering Of Up To $27.6 Million With Existing Institutional Investor
BETHESDA, Md., February 29, 2016 – Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that it has entered into definitive agreements with current institutional investors for a registered direct offering with gross proceeds of up to approximately $27.6 million, assuming exercise in full of the overallotment option described below.

As part of the transaction, the Company will immediately sell approximately 5.88 million shares of common stock at a purchase price of $1.70 per share resulting in gross proceeds to the Company of $10 million. The investors will also receive warrants to purchase up to approximately 2.94 million shares of common stock with an exercise price of $2.25 per share. The warrants will have an exercise period of five years commencing on the 6-month anniversary of the warrant issuance.

In addition, Northwest granted to the investors a 60-day overallotment option to purchase up to an additional 5.88 million shares of common stock at a purchase price of $3.00 per share, for an aggregate purchase price of approximately $17.6 million. In connection with such purchase of shares pursuant to the overallotment option, the investors will receive warrants to purchase up to 2.94 million shares of the Company’s common stock with an exercise price of $4.00 per share and an exercise period of five years commencing on the 6-month anniversary of the warrant issuance.

The placement is expected to close on or about March 3, 2016, subject to satisfaction of customary closing conditions. H.C. Wainwright & Co., LLC acted as the exclusive placement agent for the transaction.

The securities described above are being offered pursuant to a shelf registration statement (File No. 333-207976), which was declared effective by the United States Securities and Exchange Commission (“SEC”) on December 22, 2015. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. When filed with the SEC, copies of the prospectus supplement and the accompanying base prospectus relating to this offering may be obtained at the SEC’s website at http://www.sec.gov or by request at H.C. Wainwright & Co., LLC, at [e-mail].

[DoGood_DoWell]

LP is a shareholder of some significance, and the decisions she made regarding establishing tight control over the manufacturing, whether you agree or not, were likely made with the success of the trials in mind. When patients interests are put first, and the choice of receiving a safe and effective treatment over one that is not as safe or effective, the market will surely reward the decision to develop products with the highest efficacy, and shareholders will be rewarded. It just might not happen on the timetable that some would like.